[go: up one dir, main page]

HRP20120003T1 - Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom - Google Patents

Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom Download PDF

Info

Publication number
HRP20120003T1
HRP20120003T1 HR20120003T HRP20120003T HRP20120003T1 HR P20120003 T1 HRP20120003 T1 HR P20120003T1 HR 20120003 T HR20120003 T HR 20120003T HR P20120003 T HRP20120003 T HR P20120003T HR P20120003 T1 HRP20120003 T1 HR P20120003T1
Authority
HR
Croatia
Prior art keywords
active ingredient
complex
glycine
basic amino
ingredient complex
Prior art date
Application number
HR20120003T
Other languages
English (en)
Croatian (hr)
Inventor
Franckowiak Gerhard
Ledwoch Wolfram
Schweinheim Eberhard
Hayauchi Yutaka
Original Assignee
Bayer Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36649662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120003(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma Aktiengesellschaft filed Critical Bayer Pharma Aktiengesellschaft
Publication of HRP20120003T1 publication Critical patent/HRP20120003T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HR20120003T 2005-06-02 2006-05-20 Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom HRP20120003T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005025283A DE102005025283A1 (de) 2005-06-02 2005-06-02 Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
PCT/EP2006/004799 WO2006128600A2 (de) 2005-06-02 2006-05-20 Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin

Publications (1)

Publication Number Publication Date
HRP20120003T1 true HRP20120003T1 (hr) 2012-01-31

Family

ID=36649662

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120003T HRP20120003T1 (hr) 2005-06-02 2006-05-20 Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom

Country Status (32)

Country Link
US (1) US8063243B2 (uk)
EP (1) EP1890994B1 (uk)
JP (1) JP2008542316A (uk)
KR (1) KR101347522B1 (uk)
CN (1) CN101248036B (uk)
AR (1) AR057341A1 (uk)
AT (1) ATE526974T1 (uk)
AU (1) AU2006254429B2 (uk)
BR (1) BRPI0610734A2 (uk)
CA (1) CA2610194C (uk)
CR (1) CR9556A (uk)
CY (1) CY1112185T1 (uk)
DE (1) DE102005025283A1 (uk)
DK (1) DK1890994T3 (uk)
ES (1) ES2373917T3 (uk)
HR (1) HRP20120003T1 (uk)
IL (1) IL187772A (uk)
MA (1) MA29604B1 (uk)
MX (1) MX2007014988A (uk)
NO (1) NO20076592L (uk)
NZ (1) NZ563871A (uk)
PL (1) PL1890994T3 (uk)
PT (1) PT1890994E (uk)
RS (1) RS52111B (uk)
RU (1) RU2433995C2 (uk)
SG (1) SG162744A1 (uk)
SI (1) SI1890994T1 (uk)
TN (1) TNSN07452A1 (uk)
TW (1) TWI374740B (uk)
UA (1) UA89827C2 (uk)
WO (1) WO2006128600A2 (uk)
ZA (1) ZA200710251B (uk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008004386A1 (de) 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
RU2391986C2 (ru) * 2008-09-09 2010-06-20 Борис Иванович Блескин Средство для лечения бронхиальной астмы
CA2766048A1 (en) * 2009-06-25 2010-12-29 Tetra, Sia Novel acetylsalicylic acid salts
MX2011013750A (es) * 2009-06-25 2012-04-20 Tetra Sia Sales novedosas de acido acetilsalicilico.
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
TWI478715B (zh) * 2010-12-03 2015-04-01 Tetra Sia 新穎乙醯柳酸鹽
RU2011132483A (ru) * 2011-08-02 2013-02-10 Елена Александровна Моренко Биологически активный продукт для применения в ветеринарии и животноводстве, способ его получения и способы повышения выживаемости, стимуляции роста, иммуностимуляции и повышения общей неспецифической резистентности организма сельскохозяйственных животных
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
ITMI20121144A1 (it) * 2012-06-28 2013-12-29 Dipharma Francis Srl Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo
LV14963B (lv) 2013-06-28 2015-10-20 Tetra, Sia Endoteliālās disfunkcijas korektors
PT3419606T (pt) * 2016-02-23 2020-03-27 Merck Patent Gmbh Partículas de licina, assim como processos para a sua preparação e a sua utilização
US10882811B2 (en) 2016-12-23 2021-01-05 Aspiair Gmbh Synthesis of lysine acetylsalicylate glycine particles
JP7335232B2 (ja) * 2017-05-30 2023-08-29 ローシャン ファーマシューティカルズ，インコーポレーテッド 安定な滅菌性且つ結晶性ｏ－アセチルサリチル酸（アスピリン）のバイアル内堆積物
CN112592286B (zh) * 2020-11-23 2024-02-02 蚌埠丰原医药科技发展有限公司 一种阿司匹林与碱性氨基酸的络合物的制备方法
US20250073250A1 (en) 2022-01-05 2025-03-06 Aspiair Gmbh Improved synthesis of lysine acetylsalicylate - Glycine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS5665816A (en) * 1979-11-01 1981-06-03 Green Cross Corp:The Acetylsalicylate pharmaceutical for injection
US4446132A (en) * 1982-03-11 1984-05-01 Dynatech Laboratories Incorporated Nontoxic aspirin composition
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
FR2741534B1 (fr) * 1995-11-23 1998-09-11 Mazal Pharma Composition pharmaceutique stable a base d'acide acetylsalicylique et de tocopherol
JPH11222425A (ja) * 1997-10-27 1999-08-17 Ss Pharmaceut Co Ltd 関節疾患治療用関節内投与製剤
DE10034802A1 (de) 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
RU2203064C2 (ru) * 2001-03-11 2003-04-27 Каменев Виктор Федорович Способ лечения аспириновой бронхиальной астмы
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
DE102004025535A1 (de) * 2004-05-25 2005-12-22 Bayer Healthcare Ag Kombination von Salzen der o-Acetylsalicylsäure und Alpha-Glucosidase-Inhibitoren

Also Published As

Publication number Publication date
WO2006128600A2 (de) 2006-12-07
TW200716138A (en) 2007-05-01
AR057341A1 (es) 2007-11-28
CA2610194C (en) 2013-11-05
PL1890994T3 (pl) 2012-03-30
TWI374740B (en) 2012-10-21
ZA200710251B (en) 2009-09-30
ES2373917T3 (es) 2012-02-10
NZ563871A (en) 2011-02-25
CR9556A (es) 2008-03-03
UA89827C2 (uk) 2010-03-10
NO20076592L (no) 2007-12-20
IL187772A0 (en) 2008-08-07
EP1890994A2 (de) 2008-02-27
DE102005025283A1 (de) 2006-12-07
KR20080030578A (ko) 2008-04-04
RU2007148709A (ru) 2009-07-20
US20090226524A1 (en) 2009-09-10
JP2008542316A (ja) 2008-11-27
MX2007014988A (es) 2008-02-15
DK1890994T3 (da) 2012-02-06
WO2006128600A3 (de) 2007-04-26
MA29604B1 (fr) 2008-07-01
US8063243B2 (en) 2011-11-22
PT1890994E (pt) 2012-01-05
KR101347522B1 (ko) 2014-01-02
AU2006254429B2 (en) 2011-11-10
BRPI0610734A2 (pt) 2010-07-20
SG162744A1 (en) 2010-07-29
CA2610194A1 (en) 2006-12-07
AU2006254429A1 (en) 2006-12-07
RS52111B (sr) 2012-08-31
TNSN07452A1 (en) 2009-03-17
CN101248036B (zh) 2016-03-16
EP1890994B1 (de) 2011-10-05
RU2433995C2 (ru) 2011-11-20
ATE526974T1 (de) 2011-10-15
SI1890994T1 (sl) 2012-02-29
CY1112185T1 (el) 2015-12-09
CN101248036A (zh) 2008-08-20
IL187772A (en) 2013-06-27

Similar Documents

Publication Publication Date Title
HRP20120003T1 (hr) Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom
ES2382035T3 (es) Procedimiento para modificar la formación de cristales de fármaco de micofenolato de sodio
CA2416288A1 (en) Stable salts of o-acetylsalicylic acid with basic amino acids
CN101353281A (zh) 一种功能尿素及其制备方法
JP2016536134A5 (uk)
DE3152071C2 (de) Taurinderivate, deren Herstellung und Verwendung in Arzneimitteln
Qu et al. Construction of fungicide nano delivery platform through crystal engineering for sustainable fungal control
CN101455645A (zh) 植物性大豆蛋白载体的药物微球的制备方法
CN105669543A (zh) 异甘草素烟酰胺共晶及其制备方法
HRP20250660T1 (hr) Čvrsti oblici ixazomib citrata
RS54021B1 (sr) Stabilne soli s-adenozilmetionina i postupak za njihovo dobijanje
DE2235935A1 (de) Neue derivate von trijodierten aminobenzolcarbonsaeuren, ein verfahren zu deren herstellung und deren verwendung
Grebinişan et al. Novel acyl derivatives of N-(p-aminobenzoyl)-L-glutamine encapsulated in polymeric nanocapsules with potential antitumoral activity
AT390948B (de) Verfahren zur herstellung von neuen benzamid-derivaten
CN1822837A (zh) 2－甲氧基甲基－3－(3,4－二氯苯基)－8－氮杂双环[3.2.1]辛烷酒石酸盐
Tena-Solsona et al. Self-assembled multivalent (SAMul) ligand systems with enhanced stability in the presence of human serum
CN107568234A (zh) 一种抗病毒组合物
JPS5849433A (ja) マイクロカプセルの製法
Lee et al. Microcrystallization of α-lactalbumin
CN102827056B (zh) N-芳基取代吡咯烷酮衍生物及其用途
CN102246813A (zh) 阿维·毒死蜱乳油
CN106937634A (zh) 一种杀螨剂组合物及其使用方法
CN109336705A (zh) 一种微碳超敏素复合肥
CN106282251A (zh) 一种磷脂酰乙醇胺的制备方法
RU2102880C1 (ru) Способ получения препарата на основе n-( альфа гексилоксиметил)капролактама